Lin NM - Search Results

1

Deacetylisovaltratum disrupts microtubule dynamics and causes G₂/M-phase arrest in human gastric cancer cells in vitro.

Zhang D, Zhang B, Zhou LX, Zhao J, Yan YY, Li YL, Zeng JM, Wang LL, Yang B, Lin NM. Zhang D, et al. Among authors: lin nm. Acta Pharmacol Sin. 2016 Dec;37(12):1597-1605. doi: 10.1038/aps.2016.91. Epub 2016 Sep 26. Acta Pharmacol Sin. 2016. PMID: 27665846 Free PMC article.

2

Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.

Lin NM, Zeng S, Ma SL, Fan Y, Zhong HJ, Fang L. Lin NM, et al. Acta Pharmacol Sin. 2004 Dec;25(12):1584-9. Acta Pharmacol Sin. 2004. PMID: 15569401 Free article.

3

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer.

Fan Y, Lin NM, Ma SL, Luo LH, Fang L, Huang ZY, Yu HF, Wu FQ. Fan Y, et al. Among authors: lin nm. Acta Pharmacol Sin. 2010 Jun;31(6):746-52. doi: 10.1038/aps.2010.50. Acta Pharmacol Sin. 2010. PMID: 20523345 Free PMC article. Clinical Trial.

4

Enhanced anti-tumor activity by the combination of TRAIL/Apo-2L and combretastatin A-4 against human colon cancer cells via induction of apoptosis in vitro and in vivo.

Zhang C, Wu R, Zhu H, Hu YZ, Jiang H, Lin NM, He QJ, Yang B. Zhang C, et al. Among authors: lin nm. Cancer Lett. 2011 Mar 1;302(1):11-9. doi: 10.1016/j.canlet.2010.12.001. Epub 2011 Jan 14. Cancer Lett. 2011. PMID: 21236562

5

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas.

Fan Y, Lin NM, Luo LH, Fang L, Huang ZY, Yu HF, Wu FQ. Fan Y, et al. Among authors: lin nm. Acta Pharmacol Sin. 2011 Mar;32(3):408-14. doi: 10.1038/aps.2010.217. Acta Pharmacol Sin. 2011. PMID: 21372831 Free PMC article.

6

Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1.

Zhang C, Cai TY, Zhu H, Yang LQ, Jiang H, Dong XW, Hu YZ, Lin NM, He QJ, Yang B. Zhang C, et al. Among authors: lin nm. Mol Cancer Ther. 2011 Jul;10(7):1264-75. doi: 10.1158/1535-7163.MCT-10-1091. Epub 2011 May 12. Mol Cancer Ther. 2011. PMID: 21566062

7

GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.

Zheng L, Yang W, Zhang C, Ding WJ, Zhu H, Lin NM, Wu HH, He QJ, Yang B. Zheng L, et al. Among authors: lin nm. Cancer Lett. 2011 Oct 1;309(1):27-36. doi: 10.1016/j.canlet.2011.05.011. Epub 2011 Jun 12. Cancer Lett. 2011. PMID: 21664043

8

Anti-tumor and apoptotic effects in vitro and in vivo of a traditional Chinese medicine prescription.

Fang L, Wang Z, Kong WY, Feng JG, Ma SL, Lin NM. Fang L, et al. Among authors: lin nm. Chin Med J (Engl). 2011 Nov;124(21):3583-7. Chin Med J (Engl). 2011. PMID: 22340181

9

In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L.

Zhang C, Zhou SS, Feng LY, Zhang DY, Lin NM, Zhang LH, Pan JP, Wang JB, Li J. Zhang C, et al. Among authors: lin nm. Acta Pharmacol Sin. 2013 Feb;34(2):262-70. doi: 10.1038/aps.2012.158. Epub 2012 Dec 10. Acta Pharmacol Sin. 2013. PMID: 23222270 Free PMC article.

10

Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.

Ying M, Zhou X, Zhong L, Lin N, Jing H, Luo P, Yang X, Song H, Yang B, He Q. Ying M, et al. Mol Cancer Ther. 2013 Feb;12(2):195-206. doi: 10.1158/1535-7163.MCT-12-0433. Epub 2012 Dec 13. Mol Cancer Ther. 2013. PMID: 23243061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters